Exit Interviews Examining Patient Experiences with Tirzepatide and Dulaglutide for Treatment of Type 2 Diabetes in the SURPASS-CVOT Trial.

Trulicity (dulaglutide) - Eli Lilly

Mounjaro (tirzepatide) - Eli Lilly

Zepbound (tirzepatide) - Eli Lilly

http://www.ncbi.nlm.nih.gov/pubmed/42754765

Amy K Bartee; Chanadda Chinthammit; Imre Pávó; Katie D Stewart; Kristina S Boye; Louis S Matza

Sep 18, 2026